Startup tests resistance to HIV drugs

June 8, 2014 - Boston Herald

by Marie Szaniszlo

A simple, fast, affordable test developed by a Boston-based MassChallenge finalist is able to determine which drugs HIV is resistant to, saving money and lives.

Using a technology called Pan Degenerate Amplification and Adaptation, Aldatu Biosciences allows doctors to match patients with drugs the HIV won't be resistant to, based on the genetics of the virus.

"If resistance is present, switching people to effective drugs improves quality of life and saves money by reducing the risk of new infections," Aldatu CEO David Raiser said. "If resistance is not present, money is saved by not switching patients to more expensive drugs unnecessarily. There are clear economic and public health benefits to performing the test, regardless of the result." Continue reading...

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in you in box.

seventh name
Wed, 10/22/2014 - 10:25pm
Wed, 10/22/2014 - 1:55pm
Tue, 10/21/2014 - 9:52pm
The Well Project is honored to be chosen by John Legend, RYOT and the Burkle Global Impact Initiative to join their #OperationGirl Charity Challenge, a fundraising campaign for charities focused

Get basic information about tests for resistance, tropism, and viral load – what they are, when you need them, and how they are used.

Get basic information on what anemia is, what causes it, why it is of special concern to HIV+ women, and how it is diagnosed and treated.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>